SAN JOSE, Calif.--(

加利福尼亚州圣何塞--(

BUSINESS WIRE

商业热线

)--Takara Bio USA Holdings, Inc. (“TBUSH”) today announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition combines two innovative spatial biology platforms with Takara Bio’s industry-leading portfolio of single-cell genomics tools..

)--Takara Bio USA Holdings，Inc.（“TBUSH”）今天宣布收购Curio Bioscience，这是一家空间基因组学领域的先驱公司。这项战略性收购将两个创新的空间生物学平台与Takara Bio业界领先的单细胞基因组学工具组合相结合。。

TBUSH is a wholly owned subsidiary of Takara Bio Inc. ('Takara Bio'), a leading global biotechnology and life science company headquartered in Shiga, Japan.

TBUSH是Takara Bio Inc.（“Takara Bio”）的全资子公司，Takara Bio是一家全球领先的生物技术和生命科学公司，总部位于日本滋贺。

Takara Bio USA

Takara 有机 美国

, Inc. ('TBUSA') is a wholly owned subsidiary of TBUSH. TBUSA and TBUSH are part of the global Takara Bio Group, which offers diverse life science products and services supporting discovery, translational, and clinical scientists in advancing their research.

，Inc.（“TBUSA”）是TBUSH的全资子公司。TBUSA和TBUSH是全球塔卡拉生物集团的一部分，该集团提供多种生命科学产品和服务，支持发现，转化和临床科学家推进其研究。

The

The

Curio Bioscience

古玩生物科学

acquisition will extend the power of Takara Bio’s NGS solutions and give customers deeper insights into tissue spatial organization and molecular composition. “We are proud of our history of innovation in the single-cell genomics market, having developed the first commercially available kits for single-cell RNA- and DNA-seq,” said Carol Lou, President and CEO of Takara Bio USA.

此次收购将扩大Takara Bio NGS解决方案的影响力，并为客户提供对组织空间组织和分子组成的更深入见解。Takara Bio USA总裁兼首席执行官卡罗尔·卢（CarolLou）表示：“我们为单细胞基因组学市场的创新历史感到骄傲，我们开发了第一个可商购的单细胞RNA和DNA-seq试剂盒。”。

“The acquisition of Curio Bioscience continues this legacy with the addition of Trekker, the first truly single-cell spatial technology.”.

“收购Curio Bioscience延续了这一传统，加入了Trekker，这是第一个真正的单细胞空间技术。”。

Curio’s advanced Trekker and Seeker technologies integrate spatial information with molecular data, enabling researchers to transform single-cell sequencing data into spatially resolved maps. This transformation offers high-resolution insights into the organization and function of cells within their native tissue environments..

Curio的先进Trekker和Seeker技术将空间信息与分子数据相结合，使研究人员能够将单细胞测序数据转换为空间分辨率的地图。这种转变为细胞在其天然组织环境中的组织和功能提供了高分辨率的见解。。

“Curio Bioscience is dedicated to creating innovative approaches that map the entire transcriptome with unparalleled sensitivity and resolution,” said Stephen Fodor, co-founder and CEO. “Combining Curio’s technology with Takara Bio’s vast NGS and single-cell tool set will provide customers with industry-leading solutions for their spatial biology needs.”.

“Curio Bioscience致力于创建创新方法，以无与伦比的灵敏度和分辨率绘制整个转录组，”联合创始人兼首席执行官斯蒂芬·福多尔（StephenFodor）表示。“将Curio的技术与Takara Bio的庞大NGS和单细胞工具集相结合，将为客户的空间生物学需求提供业界领先的解决方案。”。

Through these advancements, Takara Bio has solidified its position as a leader in the single-cell genomics market by continually driving innovation and supporting groundbreaking research in the life science market for a wide range of applications in cancer biology, neuroscience, developmental biology, and immunology..

通过这些进步，Takara Bio通过不断推动创新并支持生命科学市场的开创性研究，在癌症生物学，神经科学，发育生物学和免疫学领域的广泛应用，巩固了其在单细胞基因组学市场的领先地位。。

Advisors

顾问

Houlihan Lokey acted as exclusive financial advisor and Cooley LLP acted as legal advisor to Takara Bio.

Houlihan Lokey担任Takara Bio的独家财务顾问，Cooley LLP担任法律顾问。

Aquilo Partners, L.P. acted as financial advisor and Dorsey & Whitney LLP as legal advisor to Curio Bioscience.

Aquilo Partners，L.P.担任财务顾问，Dorsey＆Whitney LLP担任Curio Bioscience的法律顾问。

About Takara Bio

关于Takara Bio

Takara Bio USA, Inc. is a wholly owned subsidiary of Takara Bio Inc. that manufactures and distributes kits, reagents, and instruments for the life sciences, including NGS, PCR, gene delivery, genome editing, stem cell research, nucleic acid and protein purification, and automated sample preparation..

Takara Bio USA，Inc.是Takara Bio Inc.的全资子公司，生产和分销用于生命科学的试剂盒、试剂和仪器，包括NGS、PCR、基因传递、基因组编辑、干细胞研究、核酸和蛋白质纯化以及自动化样品制备。。

Takara Bio Inc., a world leader in biotechnology research and development, offers a host of life science research solutions, from enzymes and GMP-grade reagents to contracted cell and gene therapy manufacturing services and is the developer of the RetroNectin® reagent, a world standard in gene therapy protocols.

Takara Bio Inc.是生物技术研究和开发领域的世界领导者，提供了一系列生命科学研究解决方案，从酶和GMP级试剂到签约的细胞和基因治疗制造服务，并且是RetroNectin®试剂的开发商，RetroNectin®试剂是基因治疗方案的世界标准。

Takara Bio is committed to preventing disease and improving the quality of life for all people through the use of biotechnology. For more information, visit .

Takara Bio致力于通过使用生物技术来预防疾病并提高所有人的生活质量。有关更多信息，请访问。

takarabio.com

网站 takarabio.com

.

.

About Curio Bioscience

关于古玩生物科学

Curio Bioscience is advancing a new generation of high-precision tools for the life sciences industry. The company has developed innovative spatial biology capabilities to map the whole transcriptome at high resolution using existing sequencing workflows and instrumentation. The founding team has a strong track record of bringing genomic solutions to market.

Curio Bioscience正在为生命科学行业推进新一代高精度工具。该公司开发了创新的空间生物学功能，可以使用现有的测序工作流程和仪器以高分辨率绘制整个转录组。创始团队在将基因组解决方案推向市场方面有着良好的记录。

.

.

Curio Bioscience

古玩生物科学

is based in Palo Alto, California.

总部位于加利福尼亚州帕洛阿尔托。